Recent STOK News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 11:05:11 AM
- Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates • Business Wire • 05/06/2024 11:00:00 AM
- Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer • Business Wire • 04/29/2024 12:00:00 PM
- Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer • Business Wire • 04/17/2024 12:00:00 PM
- Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/04/2024 08:30:00 PM
- Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering • Business Wire • 03/28/2024 03:40:00 AM
- Stoke Therapeutics Announces Proposed Public Offering • Business Wire • 03/26/2024 08:07:00 PM
- Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 03/25/2024 08:01:00 PM
- Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome • Business Wire • 03/25/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:21:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:28:34 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/26/2024 03:38:58 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/26/2024 03:36:14 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:20:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:32:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 09:49:55 PM
- Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) • Business Wire • 01/17/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:09:56 PM
- Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024 • Business Wire • 01/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:38:31 PM
- Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/04/2024 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2024 09:29:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:18:54 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM